Amyloid β-Protein Fragment 25-35 is widely used in neuroscience research to study Alzheimer's disease. It is particularly valuable for inducing amyloid-related toxicity in cell cultures and animal models, helping researchers understand the mechanisms of neurodegeneration. This fragment is often employed to investigate the effects of amyloid plaques on neuronal cells, including cell death, synaptic dysfunction, and oxidative stress. Additionally, it serves as a tool for testing potential therapeutic compounds aimed at mitigating amyloid-induced damage. Its role in modeling Alzheimer's pathology makes it a critical component in the development of treatments and diagnostic strategies for the disease.